Ignite Creation Date:
2024-05-11 @ 8:30 AM
Last Modification Date:
2024-10-26 @ 3:29 PM
Study NCT ID:
NCT06408935
Status:
RECRUITING
Last Update Posted:
2024-06-10
First Post:
2024-05-07
Brief Title:
Transmural Healing and Disease-Modifying Effect of Guselkumab in Crohns Disease Patients
Sponsor:
Janssen-Cilag Ltd
Organization:
Janssen-Cilag Ltd
Organization Data
Organization:
Janssen-Cilag Ltd
Class:
INDUSTRY
Study ID:
CNTO1959CRD3008
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Janssen-Cilag Ltd
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None